10:15 am – 11:00 am – Delta 8, CBC, CBN, CBG & More Minors
The Others: Your eyes don’t deceive you. This is a CBD Expo, but there are many more therapeutic molecules in hemp, including so-called minor cannabinoids like CBC, CBN, and CBG as well as moieties that are still to be fully appreciated. Our experts assembled on this panel are hoping to familiarize consumers with the diversity of plant chemicals that cannabis has to offer. From how they are extracted, isolated, and synthesized to how they can be utilized in product formulation, this panel will aim to introduce these novel compounds and guide listeners to where they can learn and experience more. Understanding developments surrounding products, science, and culture as well as cannabis and hemp as CBD becomes increasingly mainstream is important to understanding how to unlock the full potential of the plant and understand how the industry is developing into the new decade.
11:15 am – 12:00 pm – The Cutting Edge of Cannabinoid Science
Science has transformed the world of cannabinoids. CBD was once a relatively obscure, banned substance. But scientific research landed this compound in the hands of physicians, engineers, lawmakers, and consumers. In fact, research fuels innovation. Designers rely on emerging scientific evidence to develop cannabinoid products that meet the needs of an evolving market. Where is the science of CBD today? The past year’s breakthroughs in CBD research include medication interactions, epilepsy, neuroscience, dermatological applications, mental health disorders, addiction/relapse, and biochemistry. This council of established scientists will push your company to the cutting edge of chemical/medical advancement in the field. Critics often point out that CBD claims are ahead of science. But knowledge is power.
12:00 pm – 12:30 pm – LUNCH BREAK
12:30 pm – 1:15 pm – KEYNOTE: To Be Announced
Abstract coming soon.
1:30 pm – 2:15 pm – The Future of Synthetic Cannabinoids and Their Play on Big Pharma
In the expanding world of cannabinoids, synthetically derived compounds are gaining ground. Plant-derived cannabinoids have opened up new realms in the alternative health sphere that are now ever present in the mainstream medical community. Synthetic cannabinoids pose a vast potential that has only recently gained traction in the cannabis industry and beyond. From new horizons in medicine to ongoing issues with abuse and regulation, synthetics are now being explored in full. We will examine the various commonly known synthetic cannabinoids here alongside their potential uses while taking a glance into the bright, yet still developing future these compounds possess. Alongside their trajectory is an ever-present relationship with Big Pharma as companies and corporations bent on progress and profit dip their hands into the use and development of synthetic cannabinoids.